Answers are grounded in this paper and cite their sources.
Sir, Restylane® is partially cross‐linked hyaluronic acid created via bacterial fermentation. It has been available in Europe for more than 6 years and is used for soft‐tissue augmentation of lips, wrinkles and folds. It is a colourless, transparent gel packaged in 0·7‐mL syringes. For augmentation the material is injected intradermally using a 27–30 gauge needle with the opening of the needle facing upwards.1 Previous studies have not demonstrated any serious adverse effects from the use of this filler material.1 We report a 35‐year‐old man who had been treated with 0·7 mL Restylane® for augmentation of frown lines. A few minutes after the injection he suddenly noticed discoloration at the nose. There was a violet and blue reticular pattern affecting the glabellar region, the bridge of the nose and the left side of the nose (Fig. 1). He felt no pain or discomfort. He was treated with low molecular weight heparin (Fragmin P forte® 5000 IE daily). The reticular pattern began to fade after 1 week of treatment, when the anticoagulant was discontinued. After 10 days an ulcer measuring 1 × 1 cm appeared in the glabellar region at the injection site, leading to cosmetic deformity. After 5 weeks this ulcer had healed, leaving no residual defect or cosmetic blemish.
No takes yet. Share an insight, caveat, or question.
Schanz et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: